Is This 5% Dividend Stock Making a Comeback?

Bristol-Myers Squibb, once a favorite for steady dividend lovers, has been in the bargain bin since late 2022, but it might be ready for a glow-up this July. The stock’s down over 40%, but that means its dividend yield is now a juicy 5.3%. With new drugs in the pipeline and a big cost-cutting plan, some folks are eyeing this as a classic 'buy low, get paid to wait' move. Just keep an eye on their July earnings—could be a turning point! #DividendStocks #InvestingTips #MoneyMoves #Business #Market